NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

IRADIMED CORPORATION (IRMD) Stock Analysis

IRADIMED CORPORATION (IRMD) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

IRMD

$87.81

−$0.43 (−0.49%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare IRMD with… →

IRMD Key Statistics

As of Oct 21, 2026
Trading
Open
$87.85
Previous Close
$88.24
Day's Range
87.21–88.89
52-Week Range
75.58–107.90
Volume
65.88K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.91
Valuation
Market Cap
$1.12B
P/E Ratio
49.06
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
35.79
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
13.00
EPS (ttm)Profit attributable to each share over the last twelve months.
1.79
Financials (FY)
Revenue (FY)
$83.81M+14.43%
Net Income (FY)
$22.48M+16.88%
Profit marginThe share of revenue left as profit after all costs and taxes.
26.70%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
12.79M
1-Year Return
+17.66%
Dividend and dates
Dividend
$0.80+0.91%
Ex-Dividend Date
August 14, 2026
Earnings Date
November 3, 2026
Avg Volume
121.37K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, IRMD closed at $87.81, +17.66% over 1 year.

IRADIMED CORPORATION (IRMD) has a market capitalization of $1.12B.

In fiscal 2025, IRMD reported revenue of $83.81M.

IRMD Stock Return by Calendar Year

IRADIMED CORPORATION (IRMD) 10-year return: what $10,000 became

1 year
$10,000 $11,766
+17.66%
5 years
$10,000 $26,179
+161.79%
10 years
$10,000 $97,938
+879.38%

If you had invested $10,000 in IRADIMED CORPORATION (IRMD) 10 years ago, at the close on October 21, 2016, it would have been worth $97,938 at the close on October 21, 2026: +879.38% in total, +25.63% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−9.35%
2025+79.69%
2024+16.99%
2023+75.37%
2022−37.53%
2021+102.68%
2020−2.48%
2019−4.42%
2018+61.45%
2017+36.49%
2016 (partial year)−36.93%

As of October 21, 2026.

IRMD Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$83.81M$22.48M26.8%
2024$73.24M$19.23M26.3%
2023$65.56M$17.19M26.2%
2022$53.30M$12.83M24.1%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$83.81M$64.32M$26.15M$22.48M26.8%
2024$73.24M$56.35M$21.97M$19.23M26.3%
2023$65.56M$50.16M$20.04M$17.19M26.2%
2022$53.30M$41.28M$15.63M$12.83M24.1%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

IRMD Dividend History

$1.18+162.2% vs 2024

Dividends per share, 2025 · 5 payments

YearDividends per sharePaymentsChange
2026*$0.603—
2025$1.185+162.2%
2024$0.453−73.2%
2023$1.682+68.0%
YearDividends per sharePaymentsChange
2026 (partial year)$0.603—
2025$1.185+162.2%
2024$0.453−73.2%
2023$1.682+68.0%
2022$1.001—

Most recent payment: $0.20 per share, ex-dividend August 14, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

IRMD Valuation vs Medical Devices Median

Median of 145 stocks
MetricIRMDMedical Devices medianvs median
P/E49.0627.0881% above
P/S ratio13.002.535.1x the median
Profit margin26.70%−14.78%41.5 pts above

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 11 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

IRADIMED CORPORATION (IRMD) carries a market capitalisation of $1.12B. It is classified in the Medical Devices industry, within the Healthcare sector. Headcount on file is 166.

Over the past 52 weeks the price has ranged from $75.58 to $107.90. The most recent close on file for IRMD is $87.81, dated October 21, 2026. That is −$0.43 (−0.49%) against the previous close. The latest close sits 16.18% above that 52-week low.

Financial Health

In fiscal 2025, IRADIMED CORPORATION reported revenue of $83.81M. Against the prior fiscal year total of $73.24M, that is a change of +14.43%. Net income for the same year was $22.48M. That is +16.88% against the prior fiscal year. The reported profit margin is 26.7%. That is 41.5 percentage points above the Medical Devices median of −14.78%. Trailing earnings per share are 1.79.

Across the 4 fiscal years on file, revenue moves from $53.30M in 2022 to $83.81M in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 49.06 times earnings. That is 81.17% above the Medical Devices median of 27.08. On forward earnings the ratio is 35.79. The price-to-sales ratio is 13. On price-to-sales that is 5.1 times the Medical Devices median of 2.53. 145 Medical Devices companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the total return is +17.66%. Measured over 10 years, that is +25.63% a year compounded. Beta against the wider market is reported at 0.91. Annualized volatility over the trailing 10 years is 46.58%.

Growth & Income

Shareholders receive a dividend, yielding 0.91% on the latest price. That is 0.2 percentage points below the Medical Devices median yield of 1.15%. At the indicated rate that is $0.80 a share a year. The ex-dividend date on file is August 14, 2026. Dividends are recorded for 5 calendar years; 2026 shows 3 payments totalling $0.60 a share. The year before, 2025, totalled $1.18 a share.

2026 is still running; the total return is −9.35% year to date. Across the complete calendar years on file, 2021 returned +102.68% and 2022 returned −37.53%. Of the 9 complete calendar years on file, 6 finished higher.

Peer Comparison

IRADIMED CORPORATION (IRMD) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
IRADIMED CORPORATION IRMD $1.12B 49.1
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. IRADIMED CORPORATION trades at a P/E of 49.1.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About IRADIMED CORPORATION

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.

Visit website →